• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global Hospital Injectable Drugs Market Insights and Forecast to 2026

report cover
  • 31 July 2020
  • Pharmaceuticals
  • 111 Pages
  • Report Code: 24LS-16414
  • Formate :   
Download FREE Report Sample Download PDF File

Hospital Injectable Drugs -MARKET ADVISORY SERVICES

Hospital Injectable Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hospital Injectable Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Hospital Injectable Drugs market is segmented into
Cardiology& Metabolicdisorders
Neurology
Oncology
Autoimmune
Gastroenterology
Hematology
Pain
Infectiousdiseases
Others

Segment by Application, the Hospital Injectable Drugs market is segmented into
HospitalPharmacy
RetailPharmacy
E-commerce

Regional and Country-level Analysis
The Hospital Injectable Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Hospital Injectable Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Hospital Injectable Drugs Market Share Analysis
Hospital Injectable Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hospital Injectable Drugs business, the date to enter into the Hospital Injectable Drugs market, Hospital Injectable Drugs product introduction, recent developments, etc.

The major vendors covered:
Baxter International Inc.
Sanofi
Pfizer Inc.
GlaxoSmithKline plc
AstraZeneca
Gilead
Sciences
Merck & Co.
Novartis AG
Johnson & Johnson
Novo Nordisk A/S
1 Study Coverage
1.1 Hospital Injectable Drugs Product Introduction
1.2 Market Segments
1.3 Key Hospital Injectable Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Hospital Injectable Drugs Market Size Growth Rate by Type
1.4.2 Cardiology& Metabolicdisorders
1.4.3 Neurology
1.4.4 Oncology
1.4.5 Autoimmune
1.4.6 Gastroenterology
1.4.7 Hematology
1.4.8 Pain
1.4.9 Infectiousdiseases
1.4.10 Others
1.5 Market by Application
1.5.1 Global Hospital Injectable Drugs Market Size Growth Rate by Application
1.5.2 HospitalPharmacy
1.5.3 RetailPharmacy
1.5.4 E-commerce
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Hospital Injectable Drugs Market Size, Estimates and Forecasts
2.1.1 Global Hospital Injectable Drugs Revenue 2015-2026
2.1.2 Global Hospital Injectable Drugs Sales 2015-2026
2.2 Global Hospital Injectable Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Hospital Injectable Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Hospital Injectable Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Hospital Injectable Drugs Competitor Landscape by Players
3.1 Hospital Injectable Drugs Sales by Manufacturers
3.1.1 Hospital Injectable Drugs Sales by Manufacturers (2015-2020)
3.1.2 Hospital Injectable Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Hospital Injectable Drugs Revenue by Manufacturers
3.2.1 Hospital Injectable Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Hospital Injectable Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Hospital Injectable Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Hospital Injectable Drugs Revenue in 2019
3.2.5 Global Hospital Injectable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Hospital Injectable Drugs Price by Manufacturers
3.4 Hospital Injectable Drugs Manufacturing Base Distribution, Product Types
3.4.1 Hospital Injectable Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hospital Injectable Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Hospital Injectable Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Hospital Injectable Drugs Market Size by Type (2015-2020)
4.1.1 Global Hospital Injectable Drugs Sales by Type (2015-2020)
4.1.2 Global Hospital Injectable Drugs Revenue by Type (2015-2020)
4.1.3 Hospital Injectable Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Hospital Injectable Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Hospital Injectable Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Hospital Injectable Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Hospital Injectable Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Hospital Injectable Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Hospital Injectable Drugs Market Size by Application (2015-2020)
5.1.1 Global Hospital Injectable Drugs Sales by Application (2015-2020)
5.1.2 Global Hospital Injectable Drugs Revenue by Application (2015-2020)
5.1.3 Hospital Injectable Drugs Price by Application (2015-2020)
5.2 Hospital Injectable Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Hospital Injectable Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Hospital Injectable Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Hospital Injectable Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Hospital Injectable Drugs by Country
6.1.1 North America Hospital Injectable Drugs Sales by Country
6.1.2 North America Hospital Injectable Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Hospital Injectable Drugs Market Facts & Figures by Type
6.3 North America Hospital Injectable Drugs Market Facts & Figures by Application

7 Europe
7.1 Europe Hospital Injectable Drugs by Country
7.1.1 Europe Hospital Injectable Drugs Sales by Country
7.1.2 Europe Hospital Injectable Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hospital Injectable Drugs Market Facts & Figures by Type
7.3 Europe Hospital Injectable Drugs Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Hospital Injectable Drugs by Region
8.1.1 Asia Pacific Hospital Injectable Drugs Sales by Region
8.1.2 Asia Pacific Hospital Injectable Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Hospital Injectable Drugs Market Facts & Figures by Type
8.3 Asia Pacific Hospital Injectable Drugs Market Facts & Figures by Application

9 Latin America
9.1 Latin America Hospital Injectable Drugs by Country
9.1.1 Latin America Hospital Injectable Drugs Sales by Country
9.1.2 Latin America Hospital Injectable Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Hospital Injectable Drugs Market Facts & Figures by Type
9.3 Central & South America Hospital Injectable Drugs Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Hospital Injectable Drugs by Country
10.1.1 Middle East and Africa Hospital Injectable Drugs Sales by Country
10.1.2 Middle East and Africa Hospital Injectable Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Hospital Injectable Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Hospital Injectable Drugs Market Facts & Figures by Application

11 Company Profiles
11.1 Baxter International Inc.
11.1.1 Baxter International Inc. Corporation Information
11.1.2 Baxter International Inc. Description and Business Overview
11.1.3 Baxter International Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxter International Inc. Hospital Injectable Drugs Products Offered
11.1.5 Baxter International Inc. Related Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Description and Business Overview
11.2.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sanofi Hospital Injectable Drugs Products Offered
11.2.5 Sanofi Related Developments
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Corporation Information
11.3.2 Pfizer Inc. Description and Business Overview
11.3.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer Inc. Hospital Injectable Drugs Products Offered
11.3.5 Pfizer Inc. Related Developments
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Corporation Information
11.4.2 GlaxoSmithKline plc Description and Business Overview
11.4.3 GlaxoSmithKline plc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 GlaxoSmithKline plc Hospital Injectable Drugs Products Offered
11.4.5 GlaxoSmithKline plc Related Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Description and Business Overview
11.5.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.5.4 AstraZeneca Hospital Injectable Drugs Products Offered
11.5.5 AstraZeneca Related Developments
11.6 Gilead
11.6.1 Gilead Corporation Information
11.6.2 Gilead Description and Business Overview
11.6.3 Gilead Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Gilead Hospital Injectable Drugs Products Offered
11.6.5 Gilead Related Developments
11.7 Sciences
11.7.1 Sciences Corporation Information
11.7.2 Sciences Description and Business Overview
11.7.3 Sciences Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sciences Hospital Injectable Drugs Products Offered
11.7.5 Sciences Related Developments
11.8 Merck & Co.
11.8.1 Merck & Co. Corporation Information
11.8.2 Merck & Co. Description and Business Overview
11.8.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Merck & Co. Hospital Injectable Drugs Products Offered
11.8.5 Merck & Co. Related Developments
11.9 Novartis AG
11.9.1 Novartis AG Corporation Information
11.9.2 Novartis AG Description and Business Overview
11.9.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Novartis AG Hospital Injectable Drugs Products Offered
11.9.5 Novartis AG Related Developments
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Corporation Information
11.10.2 Johnson & Johnson Description and Business Overview
11.10.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Johnson & Johnson Hospital Injectable Drugs Products Offered
11.10.5 Johnson & Johnson Related Developments
11.1 Baxter International Inc.
11.1.1 Baxter International Inc. Corporation Information
11.1.2 Baxter International Inc. Description and Business Overview
11.1.3 Baxter International Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxter International Inc. Hospital Injectable Drugs Products Offered
11.1.5 Baxter International Inc. Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Hospital Injectable Drugs Market Estimates and Projections by Region
12.1.1 Global Hospital Injectable Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Hospital Injectable Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Hospital Injectable Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Hospital Injectable Drugs Sales Forecast (2021-2026)
12.2.2 North America: Hospital Injectable Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Hospital Injectable Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Hospital Injectable Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Hospital Injectable Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Hospital Injectable Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Hospital Injectable Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Hospital Injectable Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Hospital Injectable Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Hospital Injectable Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Hospital Injectable Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Hospital Injectable Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Hospital Injectable Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Hospital Injectable Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Hospital Injectable Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Hospital Injectable Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Hospital Injectable Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Hospital Injectable Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Hospital Injectable Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Hospital Injectable Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hospital Injectable Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables

Table 1. Hospital Injectable Drugs Market Segments

Table 2. Ranking of Global Top Hospital Injectable Drugs Manufacturers by Revenue (US$ Million) in 2019

Table 3. Global Hospital Injectable Drugs Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)

Table 4. Major Manufacturers of Cardiology& Metabolicdisorders

Table 5. Major Manufacturers of Neurology

Table 6. Major Manufacturers of Oncology

Table 7. Major Manufacturers of Autoimmune

Table 8. Major Manufacturers of Gastroenterology

Table 9. Major Manufacturers of Hematology

Table 10. Major Manufacturers of Pain

Table 11. Major Manufacturers of Infectiousdiseases

Table 12. Major Manufacturers of Others

Table 13. Global Hospital Injectable Drugs Market Size Growth Rate by Application 2020-2026 (MT)

Table 14. Global Hospital Injectable Drugs Market Size by Region (MT) & (US$ Million): 2020 VS 2026

Table 15. Global Hospital Injectable Drugs Sales by Regions 2015-2020 (MT)

Table 16. Global Hospital Injectable Drugs Sales Market Share by Regions (2015-2020)

Table 17. Global Hospital Injectable Drugs Revenue by Regions 2015-2020 (US$ Million)

Table 18. Global Hospital Injectable Drugs Sales by Manufacturers (2015-2020) (MT)

Table 19. Global Hospital Injectable Drugs Sales Share by Manufacturers (2015-2020)

Table 20. Global Hospital Injectable Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)

Table 21. Global Hospital Injectable Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital Injectable Drugs as of 2019)

Table 22. Hospital Injectable Drugs Revenue by Manufacturers (2015-2020) (US$ Million)

Table 23. Hospital Injectable Drugs Revenue Share by Manufacturers (2015-2020)

Table 24. Key Manufacturers Hospital Injectable Drugs Price (2015-2020) (USD/Kg)

Table 25. Hospital Injectable Drugs Manufacturers Manufacturing Base Distribution and Headquarters

Table 26. Manufacturers Hospital Injectable Drugs Product Type

Table 27. Date of International Manufacturers Enter into Hospital Injectable Drugs Market

Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 29. Global Hospital Injectable Drugs Sales by Type (2015-2020) (MT)

Table 30. Global Hospital Injectable Drugs Sales Share by Type (2015-2020)

Table 31. Global Hospital Injectable Drugs Revenue by Type (2015-2020) (US$ Million)

Table 32. Global Hospital Injectable Drugs Revenue Share by Type (2015-2020)

Table 33. Hospital Injectable Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)

Table 34. Global Hospital Injectable Drugs Sales by Application (2015-2020) (MT)

Table 35. Global Hospital Injectable Drugs Sales Share by Application (2015-2020)

Table 36. North America Hospital Injectable Drugs Sales by Country (2015-2020) (MT)

Table 37. North America Hospital Injectable Drugs Sales Market Share by Country (2015-2020)

Table 38. North America Hospital Injectable Drugs Revenue by Country (2015-2020) (US$ Million)

Table 39. North America Hospital Injectable Drugs Revenue Market Share by Country (2015-2020)

Table 40. North America Hospital Injectable Drugs Sales by Type (2015-2020) (MT)

Table 41. North America Hospital Injectable Drugs Sales Market Share by Type (2015-2020)

Table 42. North America Hospital Injectable Drugs Sales by Application (2015-2020) (MT)

Table 43. North America Hospital Injectable Drugs Sales Market Share by Application (2015-2020)

Table 44. Europe Hospital Injectable Drugs Sales by Country (2015-2020) (MT)

Table 45. Europe Hospital Injectable Drugs Sales Market Share by Country (2015-2020)

Table 46. Europe Hospital Injectable Drugs Revenue by Country (2015-2020) (US$ Million)

Table 47. Europe Hospital Injectable Drugs Revenue Market Share by Country (2015-2020)

Table 48. Europe Hospital Injectable Drugs Sales by Type (2015-2020) (MT)

Table 49. Europe Hospital Injectable Drugs Sales Market Share by Type (2015-2020)

Table 50. Europe Hospital Injectable Drugs Sales by Application (2015-2020) (MT)

Table 51. Europe Hospital Injectable Drugs Sales Market Share by Application (2015-2020)

Table 52. Asia Pacific Hospital Injectable Drugs Sales by Region (2015-2020) (MT)

Table 53. Asia Pacific Hospital Injectable Drugs Sales Market Share by Region (2015-2020)

Table 54. Asia Pacific Hospital Injectable Drugs Revenue by Region (2015-2020) (US$ Million)

Table 55. Asia Pacific Hospital Injectable Drugs Revenue Market Share by Region (2015-2020)

Table 56. Asia Pacific Hospital Injectable Drugs Sales by Type (2015-2020) (MT)

Table 57. Asia Pacific Hospital Injectable Drugs Sales Market Share by Type (2015-2020)

Table 58. Asia Pacific Hospital Injectable Drugs Sales by Application (2015-2020) (MT)

Table 59. Asia Pacific Hospital Injectable Drugs Sales Market Share by Application (2015-2020)

Table 60. Latin America Hospital Injectable Drugs Sales by Country (2015-2020) (MT)

Table 61. Latin America Hospital Injectable Drugs Sales Market Share by Country (2015-2020)

Table 62. Latin Americaa Hospital Injectable Drugs Revenue by Country (2015-2020) (US$ Million)

Table 63. Latin America Hospital Injectable Drugs Revenue Market Share by Country (2015-2020)

Table 64. Latin America Hospital Injectable Drugs Sales by Type (2015-2020) (MT)

Table 65. Latin America Hospital Injectable Drugs Sales Market Share by Type (2015-2020)

Table 66. Latin America Hospital Injectable Drugs Sales by Application (2015-2020) (MT)

Table 67. Latin America Hospital Injectable Drugs Sales Market Share by Application (2015-2020)

Table 68. Middle East and Africa Hospital Injectable Drugs Sales by Country (2015-2020) (MT)

Table 69. Middle East and Africa Hospital Injectable Drugs Sales Market Share by Country (2015-2020)

Table 70. Middle East and Africa Hospital Injectable Drugs Revenue by Country (2015-2020) (US$ Million)

Table 71. Middle East and Africa Hospital Injectable Drugs Revenue Market Share by Country (2015-2020)

Table 72. Middle East and Africa Hospital Injectable Drugs Sales by Type (2015-2020) (MT)

Table 73. Middle East and Africa Hospital Injectable Drugs Sales Market Share by Type (2015-2020)

Table 74. Middle East and Africa Hospital Injectable Drugs Sales by Application (2015-2020) (MT)

Table 75. Middle East and Africa Hospital Injectable Drugs Sales Market Share by Application (2015-2020)

Table 76. Baxter International Inc. Corporation Information

Table 77. Baxter International Inc. Description and Major Businesses

Table 78. Baxter International Inc. Hospital Injectable Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 79. Baxter International Inc. Product

Table 80. Baxter International Inc. Recent Development

Table 81. Sanofi Corporation Information

Table 82. Sanofi Description and Major Businesses

Table 83. Sanofi Hospital Injectable Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 84. Sanofi Product

Table 85. Sanofi Recent Development

Table 86. Pfizer Inc. Corporation Information

Table 87. Pfizer Inc. Description and Major Businesses

Table 88. Pfizer Inc. Hospital Injectable Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 89. Pfizer Inc. Product

Table 90. Pfizer Inc. Recent Development

Table 91. GlaxoSmithKline plc Corporation Information

Table 92. GlaxoSmithKline plc Description and Major Businesses

Table 93. GlaxoSmithKline plc Hospital Injectable Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 94. GlaxoSmithKline plc Product

Table 95. GlaxoSmithKline plc Recent Development

Table 96. AstraZeneca Corporation Information

Table 97. AstraZeneca Description and Major Businesses

Table 98. AstraZeneca Hospital Injectable Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 99. AstraZeneca Product

Table 100. AstraZeneca Recent Development

Table 101. Gilead Corporation Information

Table 102. Gilead Description and Major Businesses

Table 103. Gilead Hospital Injectable Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 104. Gilead Product

Table 105. Gilead Recent Development

Table 106. Sciences Corporation Information

Table 107. Sciences Description and Major Businesses

Table 108. Sciences Hospital Injectable Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 109. Sciences Product

Table 110. Sciences Recent Development

Table 111. Merck & Co. Corporation Information

Table 112. Merck & Co. Description and Major Businesses

Table 113. Merck & Co. Hospital Injectable Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 114. Merck & Co. Product

Table 115. Merck & Co. Recent Development

Table 116. Novartis AG Corporation Information

Table 117. Novartis AG Description and Major Businesses

Table 118. Novartis AG Hospital Injectable Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 119. Novartis AG Product

Table 120. Novartis AG Recent Development

Table 121. Johnson & Johnson Corporation Information

Table 122. Johnson & Johnson Description and Major Businesses

Table 123. Johnson & Johnson Hospital Injectable Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 124. Johnson & Johnson Product

Table 125. Johnson & Johnson Recent Development

Table 126. Novo Nordisk A/S Corporation Information

Table 127. Novo Nordisk A/S Description and Major Businesses

Table 128. Novo Nordisk A/S Hospital Injectable Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 129. Novo Nordisk A/S Product

Table 130. Novo Nordisk A/S Recent Development

Table 131. Global Hospital Injectable Drugs Sales Forecast by Regions (2021-2026) (MT)

Table 132. Global Hospital Injectable Drugs Sales Market Share Forecast by Regions (2021-2026)

Table 133. Global Hospital Injectable Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)

Table 134. Global Hospital Injectable Drugs Revenue Market Share Forecast by Regions (2021-2026)

Table 135. North America: Hospital Injectable Drugs Sales Forecast by Country (2021-2026) (MT)

Table 136. North America: Hospital Injectable Drugs Revenue Forecast by Country (2021-2026) (US$ Million)

Table 137. Europe: Hospital Injectable Drugs Sales Forecast by Country (2021-2026) (MT)

Table 138. Europe: Hospital Injectable Drugs Revenue Forecast by Country (2021-2026) (US$ Million)

Table 139. Asia Pacific: Hospital Injectable Drugs Sales Forecast by Region (2021-2026) (MT)

Table 140. Asia Pacific: Hospital Injectable Drugs Revenue Forecast by Region (2021-2026) (US$ Million)

Table 141. Latin America: Hospital Injectable Drugs Sales Forecast by Country (2021-2026) (MT)

Table 142. Latin America: Hospital Injectable Drugs Revenue Forecast by Country (2021-2026) (US$ Million)

Table 143. Middle East and Africa: Hospital Injectable Drugs Sales Forecast by Country (2021-2026) (MT)

Table 144. Middle East and Africa: Hospital Injectable Drugs Revenue Forecast by Country (2021-2026) (US$ Million)

Table 145. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 146. Key Challenges

Table 147. Market Risks

Table 148. Main Points Interviewed from Key Hospital Injectable Drugs Players

Table 149. Hospital Injectable Drugs Customers List

Table 150. Hospital Injectable Drugs Distributors List

Table 151. Research Programs/Design for This Report

Table 152. Key Data Information from Secondary Sources

Table 153. Key Data Information from Primary Sources

List of Figures

Figure 1. Hospital Injectable Drugs Product Picture

Figure 2. Global Hospital Injectable Drugs Sales Market Share by Type in 2020 & 2026

Figure 3. Cardiology& Metabolicdisorders Product Picture

Figure 4. Neurology Product Picture

Figure 5. Oncology Product Picture

Figure 6. Autoimmune Product Picture

Figure 7. Gastroenterology Product Picture

Figure 8. Hematology Product Picture

Figure 9. Pain Product Picture

Figure 10. Infectiousdiseases Product Picture

Figure 11. Others Product Picture

Figure 12. Global Hospital Injectable Drugs Sales Market Share by Application in 2020 & 2026

Figure 13. HospitalPharmacy

Figure 14. RetailPharmacy

Figure 15. E-commerce

Figure 16. Hospital Injectable Drugs Report Years Considered

Figure 17. Global Hospital Injectable Drugs Market Size 2015-2026 (US$ Million)

Figure 18. Global Hospital Injectable Drugs Sales 2015-2026 (MT)

Figure 19. Global Hospital Injectable Drugs Market Size Market Share by Region: 2020 Versus 2026

Figure 20. Global Hospital Injectable Drugs Sales Market Share by Region (2015-2020)

Figure 21. Global Hospital Injectable Drugs Sales Market Share by Region in 2019

Figure 22. Global Hospital Injectable Drugs Revenue Market Share by Region (2015-2020)

Figure 23. Global Hospital Injectable Drugs Revenue Market Share by Region in 2019

Figure 24. Global Hospital Injectable Drugs Sales Share by Manufacturer in 2019

Figure 25. The Top 10 and 5 Players Market Share by Hospital Injectable Drugs Revenue in 2019

Figure 26. Hospital Injectable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 27. Global Hospital Injectable Drugs Sales Market Share by Type (2015-2020)

Figure 28. Global Hospital Injectable Drugs Sales Market Share by Type in 2019

Figure 29. Global Hospital Injectable Drugs Revenue Market Share by Type (2015-2020)

Figure 30. Global Hospital Injectable Drugs Revenue Market Share by Type in 2019

Figure 31. Global Hospital Injectable Drugs Market Share by Price Range (2015-2020)

Figure 32. Global Hospital Injectable Drugs Sales Market Share by Application (2015-2020)

Figure 33. Global Hospital Injectable Drugs Sales Market Share by Application in 2019

Figure 34. Global Hospital Injectable Drugs Revenue Market Share by Application (2015-2020)

Figure 35. Global Hospital Injectable Drugs Revenue Market Share by Application in 2019

Figure 36. North America Hospital Injectable Drugs Sales Growth Rate 2015-2020 (MT)

Figure 37. North America Hospital Injectable Drugs Revenue Growth Rate 2015-2020 (US$ Million)

Figure 38. North America Hospital Injectable Drugs Sales Market Share by Country in 2019

Figure 39. North America Hospital Injectable Drugs Revenue Market Share by Country in 2019

Figure 40. U.S. Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)

Figure 41. U.S. Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 42. Canada Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)

Figure 43. Canada Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 44. North America Hospital Injectable Drugs Market Share by Type in 2019

Figure 45. North America Hospital Injectable Drugs Market Share by Application in 2019

Figure 46. Europe Hospital Injectable Drugs Sales Growth Rate 2015-2020 (MT)

Figure 47. Europe Hospital Injectable Drugs Revenue Growth Rate 2015-2020 (US$ Million)

Figure 48. Europe Hospital Injectable Drugs Sales Market Share by Country in 2019

Figure 49. Europe Hospital Injectable Drugs Revenue Market Share by Country in 2019

Figure 50. Germany Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)

Figure 51. Germany Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 52. France Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)

Figure 53. France Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 54. U.K. Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)

Figure 55. U.K. Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 56. Italy Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)

Figure 57. Italy Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 58. Russia Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)

Figure 59. Russia Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 60. Europe Hospital Injectable Drugs Market Share by Type in 2019

Figure 61. Europe Hospital Injectable Drugs Market Share by Application in 2019

Figure 62. Asia Pacific Hospital Injectable Drugs Sales Growth Rate 2015-2020 (MT)

Figure 63. Asia Pacific Hospital Injectable Drugs Revenue Growth Rate 2015-2020 (US$ Million)

Figure 64. Asia Pacific Hospital Injectable Drugs Sales Market Share by Region in 2019

Figure 65. Asia Pacific Hospital Injectable Drugs Revenue Market Share by Region in 2019

Figure 66. China Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)

Figure 67. China Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 68. Japan Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)

Figure 69. Japan Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 70. South Korea Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)

Figure 71. South Korea Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 72. India Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)

Figure 73. India Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 74. Australia Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)

Figure 75. Australia Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 76. Taiwan Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)

Figure 77. Taiwan Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 78. Indonesia Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)

Figure 79. Indonesia Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 80. Thailand Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)

Figure 81. Thailand Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 82. Malaysia Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)

Figure 83. Malaysia Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 84. Philippines Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)

Figure 85. Philippines Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 86. Vietnam Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)

Figure 87. Vietnam Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 88. Asia Pacific Hospital Injectable Drugs Market Share by Type in 2019

Figure 89. Asia Pacific Hospital Injectable Drugs Market Share by Application in 2019

Figure 90. Latin America Hospital Injectable Drugs Sales Growth Rate 2015-2020 (MT)

Figure 91. Latin America Hospital Injectable Drugs Revenue Growth Rate 2015-2020 (US$ Million)

Figure 92. Latin America Hospital Injectable Drugs Sales Market Share by Country in 2019

Figure 93. Latin America Hospital Injectable Drugs Revenue Market Share by Country in 2019

Figure 94. Mexico Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)

Figure 95. Mexico Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 96. Brazil Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)

Figure 97. Brazil Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 98. Argentina Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)

Figure 99. Argentina Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 100. Latin America Hospital Injectable Drugs Market Share by Type in 2019

Figure 101. Latin America Hospital Injectable Drugs Market Share by Application in 2019

Figure 102. Middle East and Africa Hospital Injectable Drugs Sales Growth Rate 2015-2020 (MT)

Figure 103. Middle East and Africa Hospital Injectable Drugs Revenue Growth Rate 2015-2020 (US$ Million)

Figure 104. Middle East and Africa Hospital Injectable Drugs Sales Market Share by Country in 2019

Figure 105. Middle East and Africa Hospital Injectable Drugs Revenue Market Share by Country in 2019

Figure 106. Turkey Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)

Figure 107. Turkey Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 108. Saudi Arabia Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)

Figure 109. Saudi Arabia Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 110. U.A.E Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)

Figure 111. U.A.E Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 112. Middle East and Africa Hospital Injectable Drugs Market Share by Type in 2019

Figure 113. Middle East and Africa Hospital Injectable Drugs Market Share by Application in 2019

Figure 114. North America Hospital Injectable Drugs Sales Growth Rate Forecast (2021-2026) (MT)

Figure 115. North America Hospital Injectable Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 116. Europe Hospital Injectable Drugs Sales Growth Rate Forecast (2021-2026) (MT)

Figure 117. Europe Hospital Injectable Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 118. Asia Pacific Hospital Injectable Drugs Sales Growth Rate Forecast (2021-2026) (MT)

Figure 119. Asia Pacific Hospital Injectable Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 120. Latin America Hospital Injectable Drugs Sales Growth Rate Forecast (2021-2026) (MT)

Figure 121. Latin America Hospital Injectable Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 122. Middle East and Africa Hospital Injectable Drugs Sales Growth Rate Forecast (2021-2026) (MT)

Figure 123. Middle East and Africa Hospital Injectable Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 124. Porter's Five Forces Analysis

Figure 125. Channels of Distribution

Figure 126. Distributors Profiles

Figure 127. Bottom-up and Top-down Approaches for This Report

Figure 128. Data Triangulation

Figure 129. Key Executives Interviewed

Baxter International Inc.

Sanofi

Pfizer Inc.

GlaxoSmithKline plc

AstraZeneca

Gilead

Sciences

Merck & Co.

Novartis AG

Johnson & Johnson

Novo Nordisk A/S

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $2964

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase